comparemela.com

Page 19 - தீர்ப்பியல்ட் மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotech Boom - DBusiness Magazine

DBusiness Magazine Biotech Boom As Ann Arbor begins to fulfill its potential as a dynamic biotech hub, the broader impact could be profound. Cameron McCausland // Photograph by Austin Phillips There are few circumstances that better illustrate the importance of biomedical innovation than what’s happening in society right now. Across the country and around the world, the potential for new ideas, new medicines, and new therapeutic options to, quite literally, change lives has perhaps never been more apparent. Biotech breakthroughs require not only cutting-edge scientific and medical resources and expertise, but the necessary entrepreneurial energy to create and sustain them. It’s a rare and valuable combination.

Lumos Pharma Announces Changes to its Board of Directors

Share: AUSTIN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the appointment of An van Es-Johansson, M.D., to its Board of Directors, effective immediately, where she will serve as a member of the Nominating and Governance Committee. Dr. van Es-Johansson brings over 30 years of experience in executive and clinical development roles in the pharmaceutical industry. Dr. van Es-Johansson will succeed Emmett Cunningham who is resigning his Board position to focus on other professional obligations in his managerial role at Blackstone Life Sciences. We are excited to welcome Dr. An van Es-Johansson to our Board, said Rick Hawkins, CEO, President and Chairman. Dr. van Es-Johansson s clinical and corporate experience focused on growth hormone disorders and other rare diseases will be of immense value to Lumos Pharma as we pursue our clinical and business developme

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.